These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15075996)

  • 1. Side effects of azathioprine in patients with Crohn's disease.
    de Jong DJ; Goullet M; Naber TH
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):207-12. PubMed ID: 15075996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH
    Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
    Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
    Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of thiopurine methyltransferase genotype or phenotype optimizes initial dosing of azathioprine for the treatment of Crohn's disease.
    Regueiro M; Mardini H
    J Clin Gastroenterol; 2002 Sep; 35(3):240-4. PubMed ID: 12192200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Eksteen B; Ghosh S; Panaccione R
    World J Gastroenterol; 2015 Jul; 21(25):7795-804. PubMed ID: 26167079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine dose escalation in inflammatory bowel disease.
    Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
    Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiating azathioprine for Crohn's disease.
    Levesque BG; Loftus EV
    Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
    Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
    Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.
    Viazis N; Koukouratos T; Anastasiou J; Giakoumis M; Triantos C; Tsolias C; Theocharis G; Karamanolis DG
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR; Kreisel W; Schwab M; Schoelmerich J; Fleig WE; Ruhl A; Reinshagen M; Deibert P; Fellermann K; Greinwald R; Stange EF
    Aliment Pharmacol Ther; 2003 Feb; 17(4):503-8. PubMed ID: 12622758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab- and azathioprine-related severe neutropenia and thrombocytopenia in a case with Crohn's disease.
    Köksal AR; Alkim C; Altinkaya E; Buğdaci MS; Özdoğan O; Boğa S; Alkim H; Sökmen M
    Turk J Gastroenterol; 2011 Oct; 22(5):537-9. PubMed ID: 22234764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA; Hanauer SB; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):312-8. PubMed ID: 17873743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
    Chaparro M; Ordás I; Cabré E; Garcia-Sanchez V; Bastida G; Peñalva M; Gomollón F; García-Planella E; Merino O; Gutiérrez A; Esteve M; Márquez L; Garcia-Sepulcre M; Hinojosa J; Vera I; Muñoz F; Mendoza JL; Cabriada JL; Montoro MA; Barreiro-de Acosta M; Ceña G; Saro C; Aldeguer X; Barrio J; Maté J; Gisbert JP
    Inflamm Bowel Dis; 2013 Jun; 19(7):1404-10. PubMed ID: 23665964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Azathioprine toxicity in Crohn's disease: incidence, approach and course].
    Colli MV; Amaro TA; Pinto AL; Gaburri PD; Chebli JM
    Rev Assoc Med Bras (1992); 2008; 54(5):415-21. PubMed ID: 18989561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroids may prevent leukopenia, interfering with response to IV azathioprine in treatment of Crohn's disease.
    Korelitz BI
    Gastroenterology; 2000 Jun; 118(6):1281-2. PubMed ID: 10866522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.